TY - JOUR AU - Ryan, D. P. AU - Hong, T. S. AU - Bardeesy, N. PY - 2014 DA - 2014// TI - Pancreatic adenocarcinoma JO - N Engl J Med VL - 371 UR - https://doi.org/10.1056/NEJMra1404198 DO - 10.1056/NEJMra1404198 ID - Ryan2014 ER - TY - JOUR AU - Hidalgo, M. PY - 2012 DA - 2012// TI - New insights into pancreatic cancer biology JO - Ann Oncol VL - 23 UR - https://doi.org/10.1093/annonc/mds313 DO - 10.1093/annonc/mds313 ID - Hidalgo2012 ER - TY - JOUR AU - Apte, M. V. AU - Xu, Z. AU - Pothula, S. AU - Goldstein, D. AU - Pirola, R. C. AU - Wilson, J. S. PY - 2015 DA - 2015// TI - Pancreatic cancer: the microenvironment needs attention too! JO - Pancreatology VL - 15 UR - https://doi.org/10.1016/j.pan.2015.02.013 DO - 10.1016/j.pan.2015.02.013 ID - Apte2015 ER - TY - JOUR AU - Poschke, I. AU - Kiessling, R. PY - 2012 DA - 2012// TI - On the armament and appearances of human myeloid-derived suppressor cells JO - Clin Immunol VL - 144 UR - https://doi.org/10.1016/j.clim.2012.06.003 DO - 10.1016/j.clim.2012.06.003 ID - Poschke2012 ER - TY - JOUR AU - Gabrilovich, D. I. AU - Nagaraj, S. PY - 2009 DA - 2009// TI - Myeloid-derived suppressor cells as regulators of the immune system JO - Nat Rev Immunol VL - 9 UR - https://doi.org/10.1038/nri2506 DO - 10.1038/nri2506 ID - Gabrilovich2009 ER - TY - JOUR AU - Clark, C. E. AU - Hingorani, S. R. AU - Mick, R. AU - Combs, C. AU - Tuveson, D. A. AU - Vonderheide, R. H. PY - 2007 DA - 2007// TI - Dynamics of the immune reaction to pancreatic cancer from inception to invasion JO - Cancer Res VL - 67 UR - https://doi.org/10.1158/0008-5472.CAN-07-0175 DO - 10.1158/0008-5472.CAN-07-0175 ID - Clark2007 ER - TY - JOUR AU - Gabitass, R. F. AU - Annels, N. E. AU - Stocken, D. D. AU - Pandha, H. A. AU - Middleton, G. W. PY - 2011 DA - 2011// TI - Elevated myeloid-derived suppressor cells in pancreatic, esophageal and gastric cancer are an independent prognostic factor and are associated with significant elevation of the Th2 cytokine interleukin-13 JO - Cancer Immunol Immunother VL - 60 UR - https://doi.org/10.1007/s00262-011-1028-0 DO - 10.1007/s00262-011-1028-0 ID - Gabitass2011 ER - TY - JOUR AU - Hiraoka, N. AU - Onozato, K. AU - Kosuge, T. AU - Hirohashi, S. PY - 2006 DA - 2006// TI - Prevalence of FOXP3+ regulatory T cells increases during the progression of pancreatic ductal adenocarcinoma and its premalignant lesions JO - Clin Cancer Res VL - 12 UR - https://doi.org/10.1158/1078-0432.CCR-06-0369 DO - 10.1158/1078-0432.CCR-06-0369 ID - Hiraoka2006 ER - TY - JOUR AU - Kreamer, K. M. PY - 2014 DA - 2014// TI - Immune Checkpoint Blockade: a New Paradigm in Treating Advanced Cancer JO - J Adv Pract Oncol VL - 5 ID - Kreamer2014 ER - TY - JOUR AU - Brahmer, J. R. AU - Tykodi, S. S. AU - Chow, L. Q. AU - Hwu, W. J. AU - Topalian, S. L. AU - Hwu, P. AU - Drake, C. G. AU - Camacho, L. H. AU - Kauh, J. AU - Odunsi, K. PY - 2012 DA - 2012// TI - Safety and activity of anti-PD-L1 antibody in patients with advanced cancer JO - N Engl J Med VL - 366 UR - https://doi.org/10.1056/NEJMoa1200694 DO - 10.1056/NEJMoa1200694 ID - Brahmer2012 ER - TY - JOUR AU - Royal, R. E. AU - Levy, C. AU - Turner, K. AU - Mathur, A. AU - Hughes, M. AU - Kammula, U. S. AU - Sherry, R. M. AU - Topalian, S. L. AU - Yang, J. C. AU - Lowy, I. AU - Rosenberg, S. A. PY - 2010 DA - 2010// TI - Phase 2 trial of single agent Ipilimumab (anti-CTLA-4) for locally advanced or metastatic pancreatic adenocarcinoma JO - J Immunother VL - 33 UR - https://doi.org/10.1097/CJI.0b013e3181eec14c DO - 10.1097/CJI.0b013e3181eec14c ID - Royal2010 ER - TY - JOUR AU - Soares, K. C. AU - Rucki, A. A. AU - Wu, A. A. AU - Olino, K. AU - Xiao, Q. AU - Chai, Y. AU - Wamwea, A. AU - Bigelow, E. AU - Lutz, E. AU - Liu, L. PY - 2015 DA - 2015// TI - PD-1/PD-L1 blockade together with vaccine therapy facilitates effector T-cell infiltration into pancreatic tumors JO - J Immunother VL - 38 UR - https://doi.org/10.1097/CJI.0000000000000062 DO - 10.1097/CJI.0000000000000062 ID - Soares2015 ER - TY - JOUR AU - Winograd, R. AU - Byrne, K. T. AU - Evans, R. A. AU - Odorizzi, P. M. AU - Meyer, A. R. AU - Bajor, D. L. AU - Clendenin, C. AU - Stanger, B. Z. AU - Furth, E. E. AU - Wherry, E. J. AU - Vonderheide, R. H. PY - 2015 DA - 2015// TI - Induction of T-cell immunity overcomes complete resistance to PD-1 and CTLA-4 blockade and improves survival in pancreatic carcinoma JO - Cancer Immunol Res VL - 3 UR - https://doi.org/10.1158/2326-6066.CIR-14-0215 DO - 10.1158/2326-6066.CIR-14-0215 ID - Winograd2015 ER - TY - JOUR AU - Thota, R. AU - Pauff, J. M. AU - Berlin, J. D. PY - 2014 DA - 2014// TI - Treatment of metastatic pancreatic adenocarcinoma: a review JO - Oncology (Williston Park) VL - 28 ID - Thota2014 ER - TY - JOUR AU - Vizio, B. AU - Novarino, A. AU - Giacobino, A. AU - Cristiano, C. AU - Prati, A. AU - Ciuffreda, L. AU - Montrucchio, G. AU - Bellone, G. PY - 2012 DA - 2012// TI - Potential plasticity of T regulatory cells in pancreatic carcinoma in relation to disease progression and outcome JO - Exp Ther Med VL - 4 ID - Vizio2012 ER - TY - JOUR AU - Liu, W. AU - Putnam, A. L. AU - Xu-Yu, Z. AU - Szot, G. L. AU - Lee, M. R. AU - Zhu, S. AU - Gottlieb, P. A. AU - Kapranov, P. AU - Gingeras, T. R. AU - St, F. a. z. e. k. a. s. AU - Groth, B. PY - 2006 DA - 2006// TI - CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells JO - J Exp Med VL - 203 UR - https://doi.org/10.1084/jem.20060772 DO - 10.1084/jem.20060772 ID - Liu2006 ER - TY - JOUR AU - Quaresma, M. AU - Coleman, M. P. AU - Rachet, B. PY - 2015 DA - 2015// TI - 40-year trends in an index of survival for all cancers combined and survival adjusted for age and sex for each cancer in England and Wales, 1971–2011: a population-based study JO - Lancet VL - 385 UR - https://doi.org/10.1016/S0140-6736(14)61396-9 DO - 10.1016/S0140-6736(14)61396-9 ID - Quaresma2015 ER - TY - JOUR AU - Postow, M. A. AU - Chesney, J. AU - Pavlick, A. C. AU - Robert, C. AU - Grossmann, K. AU - McDermott, D. AU - Linette, G. P. AU - Meyer, N. AU - Giguere, J. K. AU - Agarwala, S. S. PY - 2015 DA - 2015// TI - Nivolumab and ipilimumab versus ipilimumab in untreated melanoma JO - N Engl J Med VL - 372 UR - https://doi.org/10.1056/NEJMoa1414428 DO - 10.1056/NEJMoa1414428 ID - Postow2015 ER - TY - JOUR AU - Pardoll, D. M. PY - 2012 DA - 2012// TI - The blockade of immune checkpoints in cancer immunotherapy JO - Nat Rev Cancer VL - 12 UR - https://doi.org/10.1038/nrc3239 DO - 10.1038/nrc3239 ID - Pardoll2012 ER - TY - JOUR AU - Gréen, H. AU - Hasmats, J. AU - Kupershmidt, I. AU - Edsgärd, D. AU - Petris, L. AU - Lewensohn, R. AU - Blackhall, F. AU - Vikingsson, S. AU - Besse, B. AU - Lindgren, A. AU - Brandén, E. PY - 2016 DA - 2016// TI - Using whole-exome sequencing to identify genetic markers for carboplatin and gemcitabine-induced toxicities JO - Clinical Cancer Research. VL - 22 UR - https://doi.org/10.1158/1078-0432.CCR-15-0964 DO - 10.1158/1078-0432.CCR-15-0964 ID - Gréen2016 ER - TY - JOUR AU - Chikamatsu, K. AU - Sakakura, K. AU - Toyoda, M. AU - Takahashi, K. AU - Yamamoto, T. AU - Masuyama, K. PY - 2012 DA - 2012// TI - Immunosuppressive activity of CD14+ HLA-DR- cells in squamous cell carcinoma of the head and neck JO - Cancer Sci VL - 103 UR - https://doi.org/10.1111/j.1349-7006.2012.02248.x DO - 10.1111/j.1349-7006.2012.02248.x ID - Chikamatsu2012 ER - TY - JOUR AU - Annels, N. E. AU - Shaw, V. E. AU - Gabitass, R. F. AU - Billingham, L. AU - Corrie, P. AU - Eatock, M. AU - Valle, J. AU - Smith, D. AU - Wadsley, J. AU - Cunningham, D. PY - 2014 DA - 2014// TI - The effects of gemcitabine and capecitabine combination chemotherapy and of low-dose adjuvant GM-CSF on the levels of myeloid-derived suppressor cells in patients with advanced pancreatic cancer JO - Cancer Immunol Immunother VL - 63 UR - https://doi.org/10.1007/s00262-013-1502-y DO - 10.1007/s00262-013-1502-y ID - Annels2014 ER - TY - JOUR AU - Khaled, Y. S. AU - Ammori, B. J. AU - Elkord, E. PY - 2014 DA - 2014// TI - Increased levels of granulocytic myeloid-derived suppressor cells in peripheral blood and tumour tissue of pancreatic cancer patients JO - J Immunol Res VL - 2014 UR - https://doi.org/10.1155/2014/879897 DO - 10.1155/2014/879897 ID - Khaled2014 ER - TY - JOUR AU - Christiansson, L. AU - Soderlund, S. AU - Mangsbo, S. AU - Hjorth-Hansen, H. AU - Hoglund, M. AU - Markevarn, B. AU - Richter, J. AU - Stenke, L. AU - Mustjoki, S. AU - Loskog, A. AU - Olsson-Stromberg, U. PY - 2015 DA - 2015// TI - The tyrosine kinase inhibitors imatinib and dasatinib reduce myeloid suppressor cells and release effector lymphocyte responses JO - Mol Cancer Ther VL - 14 UR - https://doi.org/10.1158/1535-7163.MCT-14-0849 DO - 10.1158/1535-7163.MCT-14-0849 ID - Christiansson2015 ER - TY - JOUR AU - Filipazzi, P. AU - Valenti, R. AU - Huber, V. AU - Pilla, L. AU - Canese, P. AU - Iero, M. AU - Castelli, C. AU - Mariani, L. AU - Parmiani, G. AU - Rivoltini, L. PY - 2007 DA - 2007// TI - Identification of a new subset of myeloid suppressor cells in peripheral blood of melanoma patients with modulation by a granulocyte-macrophage colony-stimulation factor-based antitumor vaccine JO - J Clin Oncol VL - 25 UR - https://doi.org/10.1200/JCO.2006.08.5829 DO - 10.1200/JCO.2006.08.5829 ID - Filipazzi2007 ER - TY - JOUR AU - Fu, B. H. AU - Fu, Z. Z. AU - Meng, W. AU - Gu, T. AU - Sun, X. D. AU - Zhang, Z. PY - 2015 DA - 2015// TI - Platelet VEGF and serum TGF-beta1 levels predict chemotherapy response in non-small cell lung cancer patients JO - Tumour Biol VL - 36 UR - https://doi.org/10.1007/s13277-015-3338-x DO - 10.1007/s13277-015-3338-x ID - Fu2015 ER - TY - JOUR AU - Germain, D. AU - Frank, D. A. PY - 2007 DA - 2007// TI - Targeting the cytoplasmic and nuclear functions of signal transducers and activators of transcription 3 for cancer therapy JO - Clin Cancer Res VL - 13 UR - https://doi.org/10.1158/1078-0432.CCR-06-2491 DO - 10.1158/1078-0432.CCR-06-2491 ID - Germain2007 ER - TY - JOUR AU - Rebe, C. AU - Vegran, F. AU - Berger, H. AU - Ghiringhelli, F. PY - 2013 DA - 2013// TI - STAT3 activation: a key factor in tumor immunoescape JO - JAKSTAT VL - 2 ID - Rebe2013 ER - TY - JOUR AU - Xu, M. Y. AU - Hu, J. J. AU - Shen, J. AU - Wang, M. L. AU - Zhang, Q. Q. AU - Qu, Y. AU - Lu, L. G. PY - 2014 DA - 2014// TI - Stat3 signaling activation crosslinking of TGF-beta1 in hepatic stellate cell exacerbates liver injury and fibrosis JO - Biochim Biophys Acta VL - 1842 UR - https://doi.org/10.1016/j.bbadis.2014.07.025 DO - 10.1016/j.bbadis.2014.07.025 ID - Xu2014 ER - TY - JOUR AU - Tang, S. N. AU - Fu, J. AU - Shankar, S. AU - Srivastava, R. K. PY - 2012 DA - 2012// TI - EGCG enhances the therapeutic potential of gemcitabine and CP690550 by inhibiting STAT3 signaling pathway in human pancreatic cancer JO - PLoS ONE VL - 7 UR - https://doi.org/10.1371/journal.pone.0031067 DO - 10.1371/journal.pone.0031067 ID - Tang2012 ER - TY - JOUR AU - Venkatasubbarao, K. AU - Peterson, L. AU - Zhao, S. AU - Hill, P. AU - Cao, L. AU - Zhou, Q. AU - Nawrocki, S. T. AU - Freeman, J. W. PY - 2013 DA - 2013// TI - Inhibiting signal transducer and activator of transcription-3 increases response to gemcitabine and delays progression of pancreatic cancer JO - Mol Cancer VL - 12 UR - https://doi.org/10.1186/1476-4598-12-104 DO - 10.1186/1476-4598-12-104 ID - Venkatasubbarao2013 ER - TY - JOUR AU - Veltkamp, S. A. AU - Beijnen, J. H. AU - Schellens, J. H. PY - 2008 DA - 2008// TI - Prolonged versus standard gemcitabine infusion: translation of molecular pharmacology to new treatment strategy JO - Oncologist VL - 13 UR - https://doi.org/10.1634/theoncologist.2007-0215 DO - 10.1634/theoncologist.2007-0215 ID - Veltkamp2008 ER - TY - JOUR AU - Ikemoto, T. AU - Yamaguchi, T. AU - Morine, Y. AU - Imura, S. AU - Soejima, Y. AU - Fujii, M. AU - Maekawa, Y. AU - Yasutomo, K. AU - Shimada, M. PY - 2006 DA - 2006// TI - Clinical roles of increased populations of Foxp3+ CD4+ T cells in peripheral blood from advanced pancreatic cancer patients JO - Pancreas VL - 33 UR - https://doi.org/10.1097/01.mpa.0000240275.68279.13 DO - 10.1097/01.mpa.0000240275.68279.13 ID - Ikemoto2006 ER - TY - JOUR AU - Wang, X. AU - Wang, L. AU - Mo, Q. AU - Dong, Y. AU - Wang, G. AU - Ji, A. PY - 2015 DA - 2015// TI - Changes of Th17/Treg cell and related cytokines in pancreatic cancer patients JO - Int J Clin Exp Pathol VL - 8 ID - Wang2015 ER - TY - JOUR AU - Homma, Y. AU - Taniguchi, K. AU - Nakazawa, M. AU - Matsuyama, R. AU - Mori, R. AU - Takeda, K. AU - Ichikawa, Y. AU - Tanaka, K. AU - Endo, I. PY - 2014 DA - 2014// TI - Changes in the immune cell population and cell proliferation in peripheral blood after gemcitabine-based chemotherapy for pancreatic cancer JO - Clin Transl Oncol VL - 16 UR - https://doi.org/10.1007/s12094-013-1079-0 DO - 10.1007/s12094-013-1079-0 ID - Homma2014 ER - TY - JOUR AU - Rettig, L. AU - Seidenberg, S. AU - Parvanova, I. AU - Samaras, P. AU - Curioni, A. AU - Knuth, A. AU - Pascolo, S. PY - 2011 DA - 2011// TI - Gemcitabine depletes regulatory T-cells in human and mice and enhances triggering of vaccine-specific cytotoxic T-cells JO - Int J Cancer VL - 129 UR - https://doi.org/10.1002/ijc.25756 DO - 10.1002/ijc.25756 ID - Rettig2011 ER - TY - JOUR AU - Plate, J. M. AU - Plate, A. E. AU - Shott, S. AU - Bograd, S. AU - Harris, J. E. PY - 2005 DA - 2005// TI - Effect of gemcitabine on immune cells in subjects with adenocarcinoma of the pancreas JO - Cancer Immunol Immunother VL - 54 UR - https://doi.org/10.1007/s00262-004-0638-1 DO - 10.1007/s00262-004-0638-1 ID - Plate2005 ER - TY - JOUR AU - Bang, S. AU - Kim, H. S. AU - Choo, Y. S. AU - Park, S. W. AU - Chung, J. B. AU - Song, S. Y. PY - 2006 DA - 2006// TI - Differences in immune cells engaged in cell-mediated immunity after chemotherapy for far advanced pancreatic cancer JO - Pancreas VL - 32 UR - https://doi.org/10.1097/01.mpa.0000191651.32420.41 DO - 10.1097/01.mpa.0000191651.32420.41 ID - Bang2006 ER -